Profile
Lacey David L. is a corporate director who, according to the most recent SEC filing dated May 15, 2026, serves as a director of Nurix Therapeutics, Inc. Nurix is a publicly traded biotechnology company focused on targeted protein degradation. The SEC filing context does not include further biographical details such as education, professional history, or prior board roles. Additional sources would be required to provide a fuller biography.
| Role | Director |
|---|
| Notability | 45/100 |
|---|
Board memberships
Awards & honors
- Serves as a director of Nurix Therapeutics, Inc. per 2026 SEC filing.
Frequently Asked Questions
Who is Lacey David L.?
Lacey David L. is a corporate director who, according to the most recent SEC filing dated May 15, 2026, serves as a director of Nurix Therapeutics, Inc. Nurix is a publicly traded biotechnology company focused on targeted protein degradation. The SEC filing context does not include further biographical details such as education, professional history, or prior board roles. Addit…
How many SEC Form 4 filings has Lacey David L. submitted recently?
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Where can I see all of Lacey David L.'s SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.